Compare Abeona Therapeutics Inc (ABEO) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Standard Lithium Ltd — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Standard Lithium Ltd is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| ABEO | SLI | |
|---|---|---|
Market Cap | $421.19M | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $7.45 | $5.65 |
52-Week Low | $4.17 | $1.93 |
Enterprise Value | $276.10M | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
